Updated on 16 October 2026: full timeline of deadlines and corrected sources.
On 27 November 2025, the European Commission published in the Official Journal the notice declaring four EUDAMED modules functional. EUDAMED is the European database on medical devices. Since 28 May 2026, using these modules has been mandatory, both for medical devices (Regulation (EU) 2017/745, MDR) and for in vitro diagnostic medical devices (Regulation (EU) 2017/746, IVDR). Catch-up periods run until May 2027. Here is what applies, to whom, and when.
What triggered the timeline
Regulation (EU) 2024/1860 changed the rule: EUDAMED no longer waits for all its modules to be ready. Each module becomes mandatory six months after the Commission publishes, in the Official Journal, a notice confirming that it works (Article 123(3) MDR; Article 113(3) IVDR).
That notice is Commission Decision (EU) 2025/2371 of 26 November 2025, published on 27 November 2025. It covers four modules:
- actor registration (manufacturers, authorised representatives, importers, system and procedure pack producers);
- the UDI database and device registration;
- notified bodies and certificates;
- market surveillance.
All the deadlines below follow from that publication.
The deadlines, in order
28 May 2026: the four modules become mandatory
- Actors. Manufacturers, authorised representatives, importers and system and procedure pack producers must be registered in the Actor module. France's ANSM specifies that this deadline applies to new operators and also to operators previously registered only with their national competent authority.
- New devices. Any device whose first unit is placed on the market from that date is registered in the UDI/Device module before it is placed on the market.
- New certificates. Notified bodies enter in EUDAMED every certificate they issue, and every decision taken on an existing certificate.
- End of national registrations for these four areas: the provisions inherited from the former directives cease to apply.
28 November 2026: devices already on the market
No later than twelve months after the notice, that is 28 November 2026, the date used by the Commission, manufacturers register in the UDI/Device module the devices placed on the market before 28 May 2026 that are still placed on the market afterwards. This covers MDR-compliant devices and so-called legacy devices, still sold under a certificate issued under the directives (Article 120(3), (3a) and (3b) MDR).
- A legacy device does not need to be registered if the corresponding device assessed under the MDR already is.
- In France, devices registered so far with ANSM must be registered again in EUDAMED before 28 November 2026, the agency points out.
- A device no longer placed on the market after 28 May 2026 is not covered by this catch-up obligation.
Read the texts carefully: this is not the date on which the UDI/Device module becomes mandatory. It has been mandatory since 28 May 2026; 28 November 2026 closes the catch-up period for devices already on the market.
27 February 2027: safety and performance summaries
The Medical Device Coordination Group (MDCG) recommends that manufacturers upload to EUDAMED the summary of safety and clinical performance (SSCP), required for implantable and class III devices, or its equivalent for class C and D in vitro diagnostic devices (SSP), as soon as possible and no later than 27 February 2027 for devices placed on the market before mandatory use (MDCG 2026-4). This is a recommendation, not a deadline set by the regulation.
28 May 2027: certificates already issued
No later than eighteen months after the notice, that is 28 May 2027, notified bodies enter in EUDAMED the certificates issued under the MDR or the IVDR before 28 May 2026. Only the latest certificate and the decisions relating to it are entered. Certificates issued under the former directives are not concerned.
No date yet: vigilance and clinical investigations
The vigilance and post-market surveillance module and the clinical investigations and performance studies module will follow the same rule: mandatory six months after a Commission notice that has not been published yet. The Commission's indicative timeline targets a notice in the fourth quarter of 2026 and mandatory use in the second quarter of 2027 for vigilance, while stating that it may change. No date has been announced for clinical investigations. Until then, national procedures apply: in France, vigilance reports go to ANSM.
What about IVDs?
The dates are the same. Decision (EU) 2025/2371 covers both regulations. The IVDR counts its periods from 28 May 2026 (six and twelve months) rather than from the notice (twelve and eighteen months), which leads to the same deadlines.
An obligation that does not end with registration
Once entered, data must stay accurate. For actors, the MDR sets precise time limits: any change to the registration information is updated in EUDAMED within one week, and the operator confirms the accuracy of its data no later than one year after submitting it, then every two years (Article 31(4) and (5)).
For devices, the issue is consistency. What is declared in EUDAMED (Basic UDI-DI, risk class, intended purpose, certificates) must match the technical documentation, the labelling, the instructions for use and the certificates. EUDAMED makes much of this information public: a gap between the database and the documentation can now be seen from the outside.
What a regulatory affairs and quality team can do now
- List the devices placed on the market before 28 May 2026 and still sold, legacy devices included, and plan their registration before 28 November 2026.
- Check actor registration: single registration number (SRN) obtained, authorised representative and importers linked, information up to date.
- Reconcile declared data with the documentation: Basic UDI-DI, class, intended purpose and certificates, against the technical documentation, labelling and instructions for use.
- Agree with the notified body on entering the MDR and IVDR certificates issued before 28 May 2026, and prepare the SSCPs or SSPs to upload.
- Prepare for vigilance: according to the Commission, the module will have no voluntary-use phase and will go live directly as mandatory.
Conclusion
EUDAMED has left the preparation phase. Since 28 May 2026, the database is the reference for actors, new devices and new certificates; 28 November 2026 closes the catch-up period for devices already on the market, and May 2027 the one for certificates. The difficulty is then no longer data entry but consistency over time between the database and the documentation. That is what a cross-review of the documents can check, such as the one EryonOne offers on the MDR and IVDR frameworks.
Bibliographie
- Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, consolidated version, Articles 31, 33, 34, 120 and 123. EUR-Lex
- Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices, OJ L, 9 July 2024. EUR-Lex
- Commission Decision (EU) 2025/2371 of 26 November 2025 on the notice regarding the functionality and the fulfilment of the functional specifications of certain electronic systems included in the European Database on Medical Devices, OJ L, 27 November 2025. EUR-Lex
- European Commission, EUDAMED overview, accessed 16 October 2026. health.ec.europa.eu
- European Commission, EUDAMED gradual roll-out: questions and answers. PDF
- European Commission, Legacy and Regulation devices placed on the market before the mandatory use, infographic. PDF
- European Commission, Certificates registration, infographic. PDF
- European Commission, EUDAMED modules timeline, November 2025. PDF
- MDCG 2026-4, Management of SS(C)P in EUDAMED after mandatory use, June 2026. PDF
- ANSM, FAQ règlement DM : Eudamed (in French), updated on 4 June 2026. ansm.sante.fr